Texas A&M Drug Discovery Center

The primary focus of the Texas A&M Drug Discovery Center is to guide targets identified by investigators through the drug discovery process and to facilitate the transition from basic research studies to drug discovery. In the past five years, we have acquired over $2 million in instrumentation to aid in drug discovery research. By consolidating resources within Texas A&M, services or consultations are available for nearly all preclinical applications in drug discovery. There are three main areas of focus within the center:

• Facilities to support the identification and optimization of peptide therapeutics are available including phage selections, synthesis, and a variety of characterization techniques.

• We have a customizable automated screening platform made up of the largest Access Workstation in Texas and will aid in all stages of the high throughput screening process, from assay development to lead identification.

• A core focused on small molecule drug development is targeted to provide resources and consultations for synthetic methods, assay design, and computer-aided drug design.